- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Eugene Nikitin
Total 1747 results
-
Eugene NikitinUnknownAIHA - Warm Autoimmune Hemolytic AnemiaRussian Federation
-
CelgeneBeiGeneTerminatedCarcinoma, Non-Small-Cell LungSpain, United States, Japan, China, Canada, United Kingdom, Belgium, Singapore, Korea, Republic of, Netherlands, France, Romania, Greece, Germany, Taiwan, Finland, Italy, Poland, Hungary, Ireland, Portugal, New Zealand, Russian Federation
-
Nikita GuptaCompletedCOVID-19 | SARS-CoV 2United States
-
Center Eugene MarquisNot yet recruiting
-
Center Eugene MarquisRecruitingHepatocellular Carcinoma Non-resectableFrance
-
Center Eugene MarquisSuspendedResectable Intrahepatic CholangiocarcinomaFrance
-
Center Eugene MarquisCompletedOropharynx CancerFrance
-
Center Eugene MarquisCompleted
-
Center Eugene MarquisTerminated
-
Center Eugene MarquisCompletedGlioma | GlioblastomaFrance
-
Center Eugene MarquisRecruiting
-
Center Eugene MarquisRecruiting
-
Center Eugene MarquisCompletedRadiotherapy Side EffectFrance
-
Center Eugene MarquisActive, not recruitingSolid Tumor, Adult | Chemotherapy Treatment | Advanced or Metastasis StageFrance
-
Center Eugene MarquisCompleted
-
Center Eugene MarquisTerminated
-
Center Eugene MarquisWithdrawn
-
Center Eugene MarquisCompleted
-
Center Eugene MarquisCompletedOropharynx CancerFrance
-
Center Eugene MarquisCompletedLocally Advanced Malignant Neoplasm | Malignant Neoplasm of Head and NeckFrance
-
Center Eugene MarquisCompletedMalignant MelanomaFrance
-
Center Eugene MarquisCompleted
-
Center Eugene MarquisTerminated
-
Center Eugene MarquisCompleted
-
Cugene Inc.RecruitingSystemic Lupus Erythematosus | Autoimmune | SLE (Systemic Lupus)United States
-
enGene, Inc.RecruitingSuperficial Bladder Cancer | Non-muscle Invasive Bladder Cancer With Carcinoma in SituUnited States
-
Cugene Inc.Active, not recruitingSystemic Lupus ErythematosusUnited States
-
Nitin Sethi, DNBCompleted
-
Dr Nitin SethiCompletedSurgery | Thoracic DiseasesIndia
-
CelgeneCelgene CorporationCompletedLymphoma | CancerUnited States, United Kingdom
-
Celgene CorporationCompleted
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
Celgene CorporationTerminatedColorectal CancerAustralia, Belgium, Germany, Italy, Spain, Sweden
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
Celgene CorporationCompletedSmall Cell Lung CancerUnited States
-
Celgene CorporationWithdrawnMetastatic Breast CancerUnited States
-
Celgene CorporationCompletedNeoplasms | FatigueUnited States
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States
-
CelgeneCelgene CorporationCompletedGlioma | Solid Tumor | Angioimmunoblastic T-cell Lymphoma | Chondrosarcoma | Intrahepatic CholangiocarcinomaUnited States, France
-
CelgeneCelgene CorporationTerminatedAdvanced Solid TumorsUnited States
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Spain, Australia, Canada, United Kingdom, Italy, Switzerland, Bulgaria, Poland, Ukraine, Belgium, Germany, Hungary, Ireland, Israel, Russian Federation
-
Celgene CorporationTerminated
-
Celgene CorporationCompletedRelapsed or Refractory Multiple MyelomaGermany
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
Celgene CorporationCompletedComplex Regional Pain Syndrome (RSD)United States
-
Celgene CorporationCompletedGlioblastoma | Malignant GliomasUnited States
-
CelgeneCelgene CorporationCompletedCutaneous T-cell LymphomaUnited States, France, Germany, Poland, Russian Federation, United Kingdom
-
Celgene CorporationCompletedHealthy SubjectsUnited States